MedPath

Evaluation of the Use of a Biodegradable Endoprothesis in the Prevention of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis

Not Applicable
Recruiting
Conditions
Biliary Stricture
Obstructive Jaundice
Sphincter of Oddi Dysfunction
Registration Number
NCT03977779
Lead Sponsor
Institut Paoli-Calmettes
Brief Summary

The use of an endoprothesis in a pancreatic duct is a measure to minimize the incidence and severity of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis. In this study we will evaluate the use of a Biodegradable Endoprothesis: Archimede Fast Biodegradable Pancreatic Stent in patients with high risk of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis.The ARCHIMEDES Fast biodegradable pancreatic stent will be placed during the Endoscopic Retrograde CholoangioPancreatography. The efficacy and the security of the device will be evaluated.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
46
Inclusion Criteria
  • Age>18 years
  • Patients at risk of developing a Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis (procedure and/or patient-related risk factors
Exclusion Criteria
  • Pregnant or breastfeeding women
  • Recent diagnosis (<1 month) of acute pancreatitis
  • contraindication to endoscopy
  • Hypersensitivity to indomethacine

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Percentage of patients with a complete clearance of the biodegradable stentDay 15

The degradation of the stent will be evaluated both duodenoscopy/fluoroscopy and endoscopy 15 days after its placement

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Institut Paoli Calmettes

🇫🇷

Marseille, Provence-Alpes-Côte d'Azur, France

Institut Paoli Calmettes
🇫🇷Marseille, Provence-Alpes-Côte d'Azur, France
GENRE Dominique, MD
Contact
+ 33 4 91 22 37 78
drci.up@ipc.unicancer.fr
GOUARNE Caroline, PhD
Contact
+ 33 4 91 22 37 78
drci.up@ipc.unicancer.fr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.